Home » Team


Douglass Given, MD, PhD

Currently the managing partner at G5 Partners, Doug also participates on the board of directors of both public and private companies, currently serving as chairman of the board at both Arrowhead Pharmaceuticals (NASDAQ: ARWR) and Vivaldi Biosciences. He provides expertise in biotechnology, biopharmaceuticals, specialty medical products, and healthcare innovation.

Adriaan Ligtenberg, PhD

An engineer, founding partner of PTP and a general partner in PTP Fund I, Adriaan has over 25 years of experience in creating, building, operating and exiting successful technology enterprises. In 1989, after leaving Bell Labs, he became a successful serial entrepreneur, first co-founding C-Cube Microsystems and later Storm Technology, both of which achieved successful initial public offerings. He was later the CTO at Cadence Design. He is the founder and managing partner of AllMobile Ventures.

Katie Given, MD, PhD

Dr. Katie Given Ligtenberg earned her MD, PhD, and MBA from the University of Chicago, with a focus in the genetics, molecular and cell biology of select agents, biodefense, and vaccine microbiology translational research. She served as an Innovation Associate at the Chicago Innovation Exchange serving with the investment teams for faculty new business formation. A resident in Internal Medicine at the University of Chicago Hospitals, she begins her Dermatology residency at Yale University in June 2017.

Annie Given, BS

Annie received her BS in Economics and Mathematics from the University of Southern California. Her expertise is in financial and operations management, particularly for startups; she works with Lock8 (Berlin), previously worked with Global BSN in San Francisco and was an investment banking analyst at Stifel in NYC, in the Financial Institutions Group.

Nick Leeper, MD

An associate professor of surgery and medicine at Stanford University School of Medicine, Nick’s clinical focus is in vascular medicine and cardiovascular disease. He regularly publishes on related topics in the space, holds two RO1 grants and is an active innovator.

Randy Thompson, MD

permission needed
Randy has practiced medicine with Saint Luke’s Cardiovascular Consultants since 1995. His academic history spans, Emory, Massachusetts General Hospital and Harvard Medical School, and The Mayo Clinic. He is member of the Board of Directors of the American Society of Nuclear Cardiology.

Ben Lenail

Ben is a founding officer of ALD Connect, a research consortium focused on the neuro-metabolic disease X-linked adrenoleukodystrophy (X-ALD). Currently, he serves as director of business development at Alta Devices, a solar energy startup in Sunnyvale, CA.

Karl Ronn

permission needed
Karl, an engineer, is the managing director of Innovation Portfolio Partners, a Silicon Valley-based firm that helps CEOs and the top management of Fortune 500 companies find and develop new-to-the-world products and services. He is on the advisory boards of Johns Hopkins Bloomberg School of Public Health, the University of Toledo, and Enviroscent.

Cindy Fong-Leeper, JD

Currently an associate general counsel at Facebook, Cindy holds a JD degree from University of Chicago Law School. Prior to joining Facebook in 2011, she served as an associate at Latham & Watkins in San Francisco and Menlo Park for seven years.